ProductsBack/ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)

ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)

Name: ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)
SKU: SEB919HU_U80
Availability: BackOrder

SEB919HU

Product group Assays

Overview

Supplier
Cloud-Clone Corp.
Product Name
ELISA Kit for Angiopoietin Like Protein 2 (ANGPTL2)
Delivery Days Customer
12
Assay Detection Range
0.312-20ng/mL
Assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiopoietin Like Protein 2 (ANGPTL2) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, ...
Assay Sensitivity
The minimum detectable dose of this kit is typically less than 0.125ng/mL
Assay Test Principle
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Angiopoietin Like Protein 2 (ANGPTL2). Standards or samples are then added to the ...
Assay Time
3h
Certification
Research Use Only
UNSPSC
41116158

Schneider F, Saulnier PJ, Gand E, et al. Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes. Cardiovasc Diabetol. 2018,17(1):81. doi: 10.1186/s12933-018-0725-9
Read this paper
Gellen B, Thorin-Trescases N, Sosner P, et al. ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Diabetologia. 2016,59(11):2321-2330. doi: 10.1007/s00125-016-4066-5
Read this paper
Toiyama Y, Tanaka K, Kitajima T, et al. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients. Carcinogenesis. 2015,36(12):1474-83. doi: 10.1093/carcin/bgv139
Read this paper
Toiyama Y, Tanaka K, Kitajima T, et al. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence. Clin Cancer Res. 2014,20(23):6175-86. doi: 10.1158/1078-0432.CCR-14-0007
Read this paper